Status:
NOT_YET_RECRUITING
Technologies to Improve QoL of Prostate Cancer
Lead Sponsor:
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
The M.I.O Project, which stands for Comprehensive Oncological Medicine, aims to comprehensively and multidisciplinary address the effects of prostate cancer, specifically in patients with hormone-sens...
Eligibility Criteria
Inclusion
- Patients histologically diagnosed with prostate cancer
- Metastases confirmed by validated imaging studies
- Not meet criteria for castration resistance.
Exclusion
- Do not have a smartphone device
- Refuse to participate
- Not sign the informed consent.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT06516276
Start Date
October 1 2024
End Date
December 31 2025
Last Update
July 23 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.